Read clinical review Clinical Reviews GIP/GLP-1 Dual Agonists: Class Overview Monograph A prescriber-level monograph covering the pharmacology, clinical trial data, dosing, safety, and approved indications for GIP/GLP-1 dual agonists, with tirzepatide as the class prototype
Oct 2021;48(5):803-808
Three trials that compared ALCAR treatment (1-3 g/day for 7-12 weeks) and antidepressant medications found ALCAR was as effective as antidepressants in treating depressive symptoms (95)
its about science, hormones, and support that meets you where you are
You should also look at lower concentrations of the active ingredients, as higher concentrations don't necessarily mean they'll work better or faster
PG Board & D Menon (2013) Glutathione transferases, regulators of cellular metabolism and physiology